Primary Care of the Newly Diagnosed HIV-Infected Patient in Developed Countries

  • Author: Mary W. Montgomery, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/20/18 (What's New)

Summary

  • Ongoing care should include the following tests
    • CD4+ cell count every 12 months if on stable ART with CD4+ cell count of 300-500 cells/mm3; optional if on stable ART with CD4+ cell count > 500 cells/mm3
      • More frequent monitoring recommended in patients who experience virologic rebound, develop new clinical symptoms, or develop conditions that may compromise CD4+ cell count

Action required

Keywords: Resistance Testing, Sexually Transmitted Diseases, Tuberculosis, Viral Hepatitis Coinfection

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.